BUSINESS

• Entyvio Filed for Crohn’s Disease in Japan: Takeda
  July 19, 2018

• Teva Takeda to Wind Up Sale of 48 Products towards Stable Supply
  July 18, 2018

• Xofluza Hits Primary Endpoint in High Risk Flu Patients: Shionogi
  July 18, 2018

• Chugai to Develop ROS1/TRK Inhibitor Entrectinib in Japan
  July 18, 2018

• AZ Initiates PIII Study of Nexium for Pediatric Indications at Request of AMED, Pediatric Society
  July 18, 2018

• FDA OKs Xtandi for Non-Metastatic Prostate Cancer
  July 18, 2018

• Epadel to Enter Clinical Study in China: Mochida, Sumitomo Dainippon
  July 18, 2018

• Lilly Japan Marks Opening of New Kobe Headquarters
  July 17, 2018

• Taiho Exercises Option to Gain Asian Rights to Arcus’ I/O Candidate
  July 17, 2018

• Takeda Jettisons Japan Rights to Obesity Drug OBLEAN after Long Listing Limbo
  July 17, 2018

• Ninlaro Hits Primary Endpoint in Post-Transplant Multiple Myeloma: Takeda
  July 13, 2018

• Otsuka Ventures into Antibody Space with Visterra Buyout
  July 12, 2018

• Kyushu Univ. Spinoff, Nagoya Upstart Launch Joint Research for AMD Treatment
  July 12, 2018

• 1st Patient Dosed in PIII Enfortumab Vedotin Study: Astellas/Seattle Genetics
  July 11, 2018

• Repatha Label Updated in Japan to Add CV Risk Reduction Data
  July 11, 2018

• Takeda Clinches Key US Clearance for Shire Takeover
  July 10, 2018

• Nichi-Iko Ties Up with Sunward for Malaysia, Singapore Biz
  July 10, 2018

• No Major Damage for Drug Makers, Wholesaler Logistics: West Japan Downpours
  July 10, 2018

• Ethical Drug Sales Up 2.6% in May: Crecon
  July 9, 2018

• Eisai/Biogen Say Alzheimer’s Candidate BAN2401 Delivered Positive Data at 18 Month Analysis
  July 9, 2018

ページ

• « 先頭
• ‹ Prev
• …
• 388
• 389
• 390
• 391
• 392
• 393
• 394
• 395
• 396
• …
• Next ›
• 最終 »